ASTROTECH Corp Operating Lease, Right-of-Use Asset, Amortization Expense
ASTROTECH Corp (ASTC) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $210.00 thousand for the 9-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- ASTROTECH Corp operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $72.00K, a 100.00% increase year-over-year.
- ASTROTECH Corp operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $72.00K, a 105.71% increase year-over-year.
- ASTROTECH Corp operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $66.00K, a 83.33% increase year-over-year.
- ASTROTECH Corp operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $87.00K, a 141.67% increase year-over-year.
- ASTROTECH Corp operating lease, right-of-use asset, amortization expense for fiscal 2025 was $194.00K, a 35.66% increase from fiscal 2024.
- ASTROTECH Corp operating lease, right-of-use asset, amortization expense for fiscal 2024 was $143.00K, a 16.26% increase from fiscal 2023.
- ASTROTECH Corp operating lease, right-of-use asset, amortization expense for fiscal 2023 was $123.00K, a 39.77% increase from fiscal 2022.
- ASTROTECH Corp operating lease, right-of-use asset, amortization expense for fiscal 2022 was $88.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $72.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-08-06 | $144.00K derived: sum of 2 quarters · filed 2026-08-06 | $210.00K 10-Q/A · filed 2026-08-06 | $297.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $138.00K 10-Q · filed 2026-02-13 | $225.00K derived: sum of 3 quarters · filed 2026-02-13 | $261.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | $66.00K 10-Q · filed 2025-11-13 | $153.00K derived: sum of 2 quarters · filed 2025-11-13 | $189.00K derived: sum of 3 quarters · filed 2026-08-06 | $224.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $87.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-26 | $123.00K derived: sum of 2 quarters · filed 2026-08-06 | $158.00K derived: sum of 3 quarters · filed 2026-08-06 | $194.00K 10-K · filed 2025-09-26 |
| 2025-03-31 | $36.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-08-06 | $71.00K derived: sum of 2 quarters · filed 2026-08-06 | $107.00K 10-Q/A · filed 2026-08-06 | $143.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $71.00K 10-Q · filed 2026-02-13 | $107.00K derived: sum of 3 quarters · filed 2026-02-13 | $142.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $36.00K 10-Q · filed 2025-11-13 | $72.00K derived: sum of 2 quarters · filed 2025-11-13 | $107.00K derived: sum of 3 quarters · filed 2025-11-13 | $143.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | $71.00K derived: sum of 2 quarters · filed 2025-09-26 | $107.00K derived: sum of 3 quarters · filed 2025-09-26 | $143.00K 10-K · filed 2025-09-26 |
| 2024-03-31 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $71.00K derived: sum of 2 quarters · filed 2025-05-14 | $107.00K 10-Q · filed 2025-05-14 | $144.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | $72.00K 10-Q · filed 2025-02-14 | $109.00K derived: sum of 3 quarters · filed 2025-02-14 | $145.00K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | $36.00K 10-Q · filed 2024-11-13 | $73.00K derived: sum of 2 quarters · filed 2024-11-13 | $109.00K derived: sum of 3 quarters · filed 2024-11-13 | $137.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20 | $73.00K derived: sum of 2 quarters · filed 2024-09-20 | $101.00K derived: sum of 3 quarters · filed 2024-09-20 | $123.00K 10-K · filed 2024-09-20 |
| 2023-03-31 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | $64.00K derived: sum of 2 quarters · filed 2024-05-14 | $86.00K 10-Q · filed 2024-05-14 | |
| 2022-12-31 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | $50.00K 10-Q · filed 2024-02-13 | ||
| 2022-09-30 | $22.00K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $88.00K 10-K · filed 2023-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |